" class="no-js "lang="en-US"> Inceptor Bio - Medtech Alert
Monday, September 15, 2025
Inceptor Bio | Pharmtech Focus

Inceptor Bio

About Inceptor Bio

Inceptor Bio

Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment.

To achieve this goal, we assembled a purpose-driven team, recruiting pioneers in oncology, gene therapy, cell therapy and gene editing to join our mission.

We provide a unique partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of our lab and manufacturing resources with the industry experience of our cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.

Related Story

Inceptor Bio Announces the Appointment of Dr. Mark J. Gilbert as Chair of its Scientific Advisory Board

July 28 2021

Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced today […]